Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression ; volume:38 ; number:1 ; day:15 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (15.4.2019), 1-11, 12.2019
- Creator
-
Jin, Hua
Jang, Yoonjeong
Cheng, Nian
Li, Qing
Cui, Peng-Fei
Zhou, Zhi-Wei
Jiang, Hu-Lin
Cho, Myung-Haing
Westover, Kenneth D.
Tan, Qun-You
Xu, Cheng-Xiong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1170-7
- URN
-
urn:nbn:de:101:1-2019051016070914327679
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jin, Hua
- Jang, Yoonjeong
- Cheng, Nian
- Li, Qing
- Cui, Peng-Fei
- Zhou, Zhi-Wei
- Jiang, Hu-Lin
- Cho, Myung-Haing
- Westover, Kenneth D.
- Tan, Qun-You
- Xu, Cheng-Xiong
- SpringerLink (Online service)
Other Objects (12)
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Current therapy of KRAS-mutant lung cancer
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Current therapy of KRAS-mutant lung cancer
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer